Pharmaceutical Filtration Devices Market to Witness Growth Acceleration During 2019 to 2022 by Global Market Players - GE Healthcare, Danaher Co, Parker Hannifin Co, Sartorius Stedim Biotech, Merck KGaA and Graver Technologies Etc.

Globally, the Pharmaceutical Filtration Devices Market is growing rapidly, and it is anticipated to show an exponential growth reaching approximately $23 Billion in 2022.

The Global Pharmaceutical Filtration Devices Market is growing with the sound pace. According to a recent study report published by the Market Research Future, the Global Pharmaceutical Filtration Devices Market is booming and expected to gain prominence over the forecast period growing. The market is forecasted to demonstrate a sound growth by 2022, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2022).

Pharmaceutical Filtrations Devices Market - Key Players

Some of the key players in this market are:

GE Healthcare (U.S.)
Pall Corporation (U.S.)
Parker Hannifin Corporation (U.S.)
Sartorius Stedim Biotech S.A. (France)
Merck KGaA (Germany)
Alfa Laval (Sweden)
Graver Technologies, LLC (U.S.)
Koch Membrane Systems Inc. (U.S.)
GEA Group (Germany)

Get Sample Report @ https://www.marketresearchfuture.com/sample_request/2432

Pharmaceutical Filtration Devices Market - Competitive Analysis

In September 2016- GE Healthcare acquired Biosafe Group and introduced Sefia, a state-of-the-art, multi-function platform which uses a combination of continuous-flow centrifugation, temperature control and fluidic management to enable purification, concentration, washing and final formulation during cell processing. Combined with GE Healthcare’s existing portfolio, Sefia further advances access to a single-solution manufacturing platform to enable turnkey, scalable manufacturing of cell therapies.

In May 2015- Danaher Corporation announced today that the company entered into a definitive merger agreement with Pall Corporation pursuant to which Danaher acquired all of the outstanding shares of Pall for USD 127.20 per share in cash, i.e., for a total enterprise value of approximately USD 13.8 billion, including assumed debt and net of acquired cash.

In February 2017- Parker Hannifin Corporation, completed the acquisition of CLARCOR Inc., a major manufacturer of filtration products, for approximately USD 4.3 billion in cash which included the assumption of net debt. The strategic transaction created a combined organization with a comprehensive portfolio of filtration products and technologies, offering customers a single streamlined source for all their purification and separation needs.

In April 2017- Sartorius Stedim Biotech acquired the Umetrics business (from the U.S. based MKS Instruments Group. Umetrics is a highly specialized, globally leading provider of data analytics software for modelling and optimizing development and manufacturing processes. SSB has been a cooperation partner of Umetrics since the end of 2012, distributing and co-marketing their software to major players in the biopharmaceutical industry.

Pharmaceutical Filtrations Devices Market - Intended Audience

Pharmaceutical filtration device manufacturers and suppliers
Contract Research Organizations (CROs)
Research and Development (R&D) Companies
Government & Independent Research Laboratories
Government and Independent Regulatory Authorities
Market Research and Consulting Service Providers
Academic Institutes and Universities

Pharmaceutical Filtrations Devices Market - Regional Analysis

Considering the global scenario of the market, Americas region is believed to be the largest market for Pharmaceutical filtration techniques and devices. Moreover, the European market is also growing continuously and slowly catching up with the American market. On the other hand, Asia-Pacific market is expected to grow at the fastest pace in the pharmaceutical filtration devices segment during the forecasted period. Middle East & Africa region are likely to have a limited but steady growth in the market.

Browse Complete 80 Pages Premium Research Report Enabled with Tables and Figures @ https://www.marketresearchfuture.com/reports/pharmaceutical-filtration-devices-market-2432

Pharmaceutical Filtrations Devices Market - Segments

The pharmaceutical filtrations market has been segmented on the basis of type of filtrations, product, and their application in pharmaceutical industry. On the basis of type the market has been segmented as air filtration, water filtration, chemical filtrations, Grade filtration (liquid and gas), and absorptive filtrations. Similarly, on the basis of product, the market has been segmented into membrane filters, media filters, cartridges and capsule filtration and others. On the basis of application in pharmaceutical industry the filtrations market has again segment into air purification, water purification, sterilization, cell separation, media and buffer filtrations and others.

Major Table of Content

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

Continued….

To Know More Enquire @ https://www.marketresearchfuture.com/enquiry/2432

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com

This release was published on openPR.